SCHEMBL4558656

SCHEMBL4558656

CCC(CCc1ccccc1)(C(N)=O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.49
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
KIF11 P52732 3/20 0.43
ALDH1A1 P00352 1/20 0.41
HDAC1 Q13547 1/20 0.40
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
OPRM1 P35372 1/20 0.40
DRD3 P35462 1/20 0.40
LMNA P02545 2/20 0.39
CHRM2 P08172 1/20 0.39
CYP2D6 P10635 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
KCNH2 Q12809 1/20 0.39
GRM2 Q14416 1/20 0.39
GRM3 Q14832 1/20 0.39
KEAP1 Q14145 1/20 0.39
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4558974 0.89 HTT (0.47) HTTMAPTKMT2AKIF11ALDH1A1
SCHEMBL3393536 0.87 ALDH1A1 (0.46) KIF11ALDH1A1HDAC1DRD2DRD4
SCHEMBL3631069 0.85 HTT (0.53) HTTMAPTKMT2AKIF11ALDH1A1
SCHEMBL431187 0.84 HTT (0.59) HTTMAPTKMT2AKIF11ALDH1A1
SCHEMBL4560569 0.83 HTT (0.51) HTTMAPTKMT2AKIF11ALDH1A1
SCHEMBL27927747 0.80 HTT (0.54) HTTMAPTKMT2AKIF11ALDH1A1
SCHEMBL12987254 0.79 AR (0.36) HTTKMT2AKIF11ALDH1A1LMNA
SCHEMBL28150792 0.78 HTT (0.56) HTTMAPTKMT2AKIF11ALDH1A1
SCHEMBL4560574 0.77 MAPT (0.52) HTTMAPTKMT2AKIF11ALDH1A1
SCHEMBL20541470 0.76 HTT (0.54) HTTMAPTKMT2AKIF11ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3114109-A1 INHIBITORS OF HISTONE LYSINE SPECIFIC DEMETHYLASE (LSD1) AND HISTONE DEACETYLASES (HDACS) The Johns Hopkins University (US) 2017-01-11 EP disclosed
WO-2015134973-A1 INHIBITORS OF HISTONE LYSINE SPECIFIC DEMETHYLASE (LSD1) AND HISTONE DEACETYLASES (HDACS) THE JOHNS HOPKINS UNIVERSITY (US) 2015-09-11 WO disclosed
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181943-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC11, HDAC3 HTT 1010/4885MAPT 1533/4885KMT2A 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.